Stewart Wang, M.D., Inc. – Trademark Portfolio
Entity Type: 03
Stewart Wang, M.D., Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include W MD, WANGMD, PEACHES AND CREAM, and WANG PLASTIC SURGERY. The owner is based in Pasadena, CA.
76 N. Hudson Avenue, Suite 100
Pasadena, CA 91101
Showing of trademarks Trademarks
Trademark Classifications
Stewart Wang, M.D., Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Stewart Wang, M.D., Inc. have?
Stewart Wang, M.D., Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 1 cancelled.
What trademark classes does Stewart Wang, M.D., Inc. file in?
Stewart Wang, M.D., Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Stewart Wang, M.D., Inc.'s most well-known trademarks?
Stewart Wang, M.D., Inc.'s registered trademark portfolio includes well-known marks such as W MD, WANGMD, PEACHES AND CREAM, and WANG PLASTIC SURGERY. These are among 6 currently registered trademarks in the portfolio.
What is Stewart Wang, M.D., Inc.'s trademark registration success rate?
Stewart Wang, M.D., Inc. has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.